Characteristics and treatment of epistaxis in nasopharyngeal carcinoma

IF 5.4 3区材料科学 Q2 CHEMISTRY, PHYSICAL ACS Applied Energy Materials Pub Date : 2024-10-18 DOI:10.1016/j.oraloncology.2024.107071

Wen-Bin Wu , Le Xia , Zheng-Kai Feng , Jiong-Lin Liang , Xi Ding , Si-Yuan Chen , Rui You , Ming-Yuan Chen , You-Ping Liu

{"title":"Characteristics and treatment of epistaxis in nasopharyngeal carcinoma","authors":"Wen-Bin Wu , Le Xia , Zheng-Kai Feng , Jiong-Lin Liang , Xi Ding , Si-Yuan Chen , Rui You , Ming-Yuan Chen , You-Ping Liu","doi":"10.1016/j.oraloncology.2024.107071","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To analyze the risk factors and explore effective treatments for epistaxis in nasopharyngeal carcinoma (NPC) patients.</div></div><div><h3>Methods</h3><div>From March 2006 to February 2020, 351 epistaxis patients visited our center and 195 patients meeting the inclusion criteria were enrolled in the study. Characteristics and treatments, including step-up hemostatic treatment (including medication, anterior ± posterior nostril packing, or further surgical hemostasis) and the CTPI emergency hemostasis method (including common carotid artery compression, tracheotomy / intubation, packing of nasal and nasopharynx, and interventional treatment), were analyzed.</div></div><div><h3>Results</h3><div>The median total bleeding volume was 100.0 ml (range 20–4430 ml). 126 (64.6 %) and 69 (35.4 %) patients suffered from non-massive epistaxis and massive epistaxis. The 1-year overall survival (OS) rate was 60.1 % for patients with massive epistaxis and 97.3 % for those with non-massive epistaxis treated with step-up hemostatic treatment. Among patients with massive epistaxis, the 1-year OS rate was 80.0 % for those who received CTPI and 13.3 % for those who received step-up hemostatic treatment.</div></div><div><h3>Conclusion</h3><div>ICA exposure and hemostasis failure was adverse prognostic factors for OS in NPC patients with epistaxis. The step-up hemostatic treatment is effective for controlling non-massive epistaxis. The CTPI emergency method might be an effective hemostasis treatment for NPC patients with massive epistaxis, especially those with PRNN and ICA exposure.</div></div>","PeriodicalId":4,"journal":{"name":"ACS Applied Energy Materials","volume":null,"pages":null},"PeriodicalIF":5.4000,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Energy Materials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1368837524003890","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, PHYSICAL","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

To analyze the risk factors and explore effective treatments for epistaxis in nasopharyngeal carcinoma (NPC) patients.

Methods

From March 2006 to February 2020, 351 epistaxis patients visited our center and 195 patients meeting the inclusion criteria were enrolled in the study. Characteristics and treatments, including step-up hemostatic treatment (including medication, anterior ± posterior nostril packing, or further surgical hemostasis) and the CTPI emergency hemostasis method (including common carotid artery compression, tracheotomy / intubation, packing of nasal and nasopharynx, and interventional treatment), were analyzed.

Results

The median total bleeding volume was 100.0 ml (range 20–4430 ml). 126 (64.6 %) and 69 (35.4 %) patients suffered from non-massive epistaxis and massive epistaxis. The 1-year overall survival (OS) rate was 60.1 % for patients with massive epistaxis and 97.3 % for those with non-massive epistaxis treated with step-up hemostatic treatment. Among patients with massive epistaxis, the 1-year OS rate was 80.0 % for those who received CTPI and 13.3 % for those who received step-up hemostatic treatment.

Conclusion

ICA exposure and hemostasis failure was adverse prognostic factors for OS in NPC patients with epistaxis. The step-up hemostatic treatment is effective for controlling non-massive epistaxis. The CTPI emergency method might be an effective hemostasis treatment for NPC patients with massive epistaxis, especially those with PRNN and ICA exposure.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

鼻咽癌鼻衄的特点和治疗方法

摘要] 目的分析鼻咽癌（NPC）患者鼻衄的危险因素并探讨有效的治疗方法。方法 2006年3月至2020年2月，本中心共收治351例鼻衄患者，其中195例符合纳入标准。结果总出血量的中位数为 100.0 毫升（范围为 20-4430 毫升）。非大量鼻衄和大量鼻衄患者分别为 126 人（64.6%）和 69 人（35.4%）。大面积鼻衄患者的 1 年总生存率（OS）为 60.1%，而接受加强型止血治疗的非大面积鼻衄患者的 1 年总生存率（OS）为 97.3%。在大面积鼻衄患者中，接受CTPI治疗的患者的1年OS率为80.0%，接受阶梯止血治疗的患者的1年OS率为13.3%。阶梯止血治疗对控制非严重性鼻衄有效。CTPI急救法可能是鼻咽癌大面积鼻衄患者的有效止血疗法，尤其是那些有PRNN和ICA暴露的患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

ACS Applied Energy Materials Materials Science-Materials Chemistry

CiteScore

10.30

自引率

6.20%

发文量

1368

期刊介绍： ACS Applied Energy Materials is an interdisciplinary journal publishing original research covering all aspects of materials, engineering, chemistry, physics and biology relevant to energy conversion and storage. The journal is devoted to reports of new and original experimental and theoretical research of an applied nature that integrate knowledge in the areas of materials, engineering, physics, bioscience, and chemistry into important energy applications.